Navigation Links
AGA unveils latest advances in GI research at DDW 2014
Date:5/2/2014

Chicago, IL (May 2, 2014) International leaders in the fields of gastroenterology and hepatology will gather together for Digestive Disease Week (DDW) 2014, the largest and most prestigious gastroenterology meeting, from May 3 to 6, 2014, at McCormick Place in Chicago, IL. DDW is jointly sponsored by the American Gastroenterological Association (AGA) Institute, the American Association for the Study of Liver Diseases (AASLD), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT).

AGA researchers will present exciting, cutting-edge data during the meeting that will help change the way physicians diagnose and treat gastrointestinal (GI) disorders. All data presented during DDW is embargoed until the beginning of the presentation or an official DDW press conference, whichever occurs first. A list of press activities is available at http://www.ddw.org/press. Newsroom staff can facilitate interviews with researchers presenting at the sessions highlighted below.

All sessions will be held in McCormick Place (Central Time). For more information on presentations and data being presented, visit http://www.myddw.org.

Plenary Sessions

The 2014 joint ASGE-AGA Presidential Plenary Session will take place on May 4 from 1:30 to 5 p.m. in the Arie Crown Theater.

AGA Institute President, Anil K. Rustgi, MD, AGAF, and his ASGE counterpart have invited noted experts to present on hot topics in gastroenterology and GI endoscopy. Presentations include:

  • "Have We Reached the Top for IBD Therapy?" Gary R. Lichtenstein, MD, Hospital of the University of Pennsylvania, Philadelphia
  • "Pancreatic Cancer: Have We Made Progress?" Andrew D. Rhim, MD, University of Michigan Health System, Ann Arbor
  • "Colorectal Polyps: Is the Resect and Discard Strategy Ready for Primetime?" Pro: Douglas K. Rex, MD, AGAF, Indiana University, Indianapolis; Con: Robert H. Riddell, MD, Mount Sinai Hospital, Toronto, Ontario, Canada
  • "IBS and FODMAP," Lin Chang, MD, AGAF, David Geffen School of Medicine at University of California, Los Angeles
  • "Dietary Effects of the Gut Microbiome," Gary D. Wu, MD, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • "C. Difficile Infection and Fecal Microbiota Transplantation," Colleen R. Kelly, MD, Warren Alpert Medical School of Brown University, Providence, RI
  • "HCV Therapy in 2014," David Thomas, MD, MPH, John Hopkins Center for Global Health, Baltimore, MD

AGA will also host a Basic Science Plenary Session on May 4 from 10 to 11:30 a.m. in Room S102ABC.

Late-Breaking Abstract Sessions

Two late breaking abstract sessions will highlight new data accepted for presentation at DDW:

  • Basic science late-breaking abstracts: May 6, 8 to 9:30 a.m., in Room S105A
  • Clinical science late-breaking abstracts: May 6, 10 to 11:30 a.m., Room S102ABC

Scientists present late-breaking abstracts during posters sessions on May 6, 8 a.m. to 5 p.m. ET, South Hall. Researchers will be present at their posters from noon to 2 p.m.

Other exciting data will be presented during DDW, including 61 clinical symposia, 16 research symposia, 10 translational symposia, 10 state-of-the-art lectures, six distinguished abstract plenary sessions, and other committee-sponsored and special sessions on a range of GI topics. Additionally, the AGA Institute will sponsor four curbside consultant sessions. A total of 10 focused research roundtables and focused clinical updates breakfast sessions designed to help participants choose the must-see basic science and clinical research abstracts presented during DDW will occur throughout the meeting.

AGA has also developed special tracks for minority physician-scientists and trainees and young GIs.


'/>"/>

Contact: Rachel Steigerwald
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related biology news :

1. AGA unveils latest advances in GI research at DDW® 2014
2. Vapor Corp. Unveils E-Cigarette Industrys First Biometric Technology
3. SensoMotoric Instruments Unveils SMI RED-n Consumer Eye Control Technology for Gaming and Computing
4. Hidden layer of genome unveils how plants may adapt to environments throughout the world
5. Brown unveils novel wireless brain sensor
6. Amiigo Unveils Fitness Tracker That Knows What Exercise Youre Performing
7. Synchrotron infrared unveils a mysterious microbial community
8. The Sackler Institute unveils a global research agenda for nutrition science
9. National Geographic unveils new phase of genographic project
10. Rice unveils super-efficient solar-energy technology
11. Genetic Engineering & Biotechnology News unveils Biotech Boulevard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology: